These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33222997)

  • 1. Overdiagnosis and Risks of Breast Cancer Screening.
    Neal CH; Helvie MA
    Radiol Clin North Am; 2021 Jan; 59(1):19-27. PubMed ID: 33222997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overdiagnosis in mammography screening for breast cancer].
    Huang YB; Yang L; Song FJ; Chen KX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1574-1578. PubMed ID: 29141352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's Awareness of and Responses to Messages About Breast Cancer Overdiagnosis and Overtreatment: Results From a 2016 National Survey.
    Nagler RH; Franklin Fowler E; Gollust SE
    Med Care; 2017 Oct; 55(10):879-885. PubMed ID: 28857962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in Screening Mammography.
    Swain M; Jeudy M; Pearlman MD
    Clin Obstet Gynecol; 2016 Jun; 59(2):351-61. PubMed ID: 27101240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Overdiagnosis: Impact on Screening Mammography Practices.
    Morris E; Feig SA; Drexler M; Lehman C
    Popul Health Manag; 2015 Sep; 18 Suppl 1(Suppl 1):S3-11. PubMed ID: 26414384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do we manage overdiagnosis/overtreatment in breast screening?
    Wallis MG
    Clin Radiol; 2018 Apr; 73(4):372-380. PubMed ID: 29174412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    Monticciolo DL; Helvie MA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):285-291. PubMed ID: 29091010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 18. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the overdiagnosis in breast screening programmes using a Monte Carlo simulation tool: a study of the influence of the parameters defining the programme configuration.
    Forastero C; Zamora LI; Guirado D; Lallena AM
    BMJ Open; 2019 Feb; 9(2):e023187. PubMed ID: 30782874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.